Global Human Insulin Sales Market Report 2018

Publisher Name :
Date: 07-Mar-2018
No. of pages: 105
Inquire Before Buying

In this report, the global Human Insulin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (Kg), revenue (Million USD), market share and growth rate of Human Insulin for these regions, from 2013 to 2025 (forecast), covering

- United States

- China

- Europe

- Japan

- Southeast Asia

- India

Global Human Insulin market competition by top manufacturers/players, with Human Insulin sales volume, Price (USD/G), revenue (Million USD) and market share for each manufacturer/player; the top players including

- Sanofi (France)

- Eli Lilly and Company (U.S.)

- Biocon Ltd. (India)

- Julphar (U.A.E.)

- Ypsomed AG (Switzerland)

- Becton

- Dickinson and Company (U.S.)

- Wockhardt Ltd. (India)

- B. Braun Meselgen AG (Switzerland)

- Biodel Inc(U.S.)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Short Acting Human Insulin

- Intermediate Acting Human Insulin

- Premixed Human Insulin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Insulin Dependent Diabetes Mellitus

- Non-Insulin Dependent Diabetes Mellitus

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Human Insulin Sales Market Report 2018

Table of Contents
Global Human Insulin Sales Market Report 2018
1 Human Insulin Market Overview
1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin by Product Category
1.2.1 Global Human Insulin Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Human Insulin Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Short Acting Human Insulin
1.2.4 Intermediate Acting Human Insulin
1.2.5 Premixed Human Insulin
1.3 Global Human Insulin Market by Application/End Users
1.3.1 Global Human Insulin Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Insulin Dependent Diabetes Mellitus
1.3.3 Non-Insulin Dependent Diabetes Mellitus
1.4 Global Human Insulin Market by Region
1.4.1 Global Human Insulin Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Human Insulin Status and Prospect (2013-2025)
1.4.3 China Human Insulin Status and Prospect (2013-2025)
1.4.4 Europe Human Insulin Status and Prospect (2013-2025)
1.4.5 Japan Human Insulin Status and Prospect (2013-2025)
1.4.6 Southeast Asia Human Insulin Status and Prospect (2013-2025)
1.4.7 India Human Insulin Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Human Insulin (2013-2025)
1.5.1 Global Human Insulin Sales and Growth Rate (2013-2025)
1.5.2 Global Human Insulin Revenue and Growth Rate (2013-2025)
2 Global Human Insulin Competition by Players/Suppliers, Type and Application
2.1 Global Human Insulin Market Competition by Players/Suppliers
2.1.1 Global Human Insulin Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Human Insulin Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Human Insulin (Volume and Value) by Type
2.2.1 Global Human Insulin Sales and Market Share by Type (2013-2018)
2.2.2 Global Human Insulin Revenue and Market Share by Type (2013-2018)
2.3 Global Human Insulin (Volume and Value) by Region
2.3.1 Global Human Insulin Sales and Market Share by Region (2013-2018)
2.3.2 Global Human Insulin Revenue and Market Share by Region (2013-2018)
2.4 Global Human Insulin (Volume) by Application
3 United States Human Insulin (Volume, Value and Sales Price)
3.1 United States Human Insulin Sales and Value (2013-2018)
3.1.1 United States Human Insulin Sales and Growth Rate (2013-2018)
3.1.2 United States Human Insulin Revenue and Growth Rate (2013-2018)
3.1.3 United States Human Insulin Sales Price Trend (2013-2018)
3.2 United States Human Insulin Sales Volume and Market Share by Players (2013-2018)
3.3 United States Human Insulin Sales Volume and Market Share by Type (2013-2018)
3.4 United States Human Insulin Sales Volume and Market Share by Application (2013-2018)
4 China Human Insulin (Volume, Value and Sales Price)
4.1 China Human Insulin Sales and Value (2013-2018)
4.1.1 China Human Insulin Sales and Growth Rate (2013-2018)
4.1.2 China Human Insulin Revenue and Growth Rate (2013-2018)
4.1.3 China Human Insulin Sales Price Trend (2013-2018)
4.2 China Human Insulin Sales Volume and Market Share by Players (2013-2018)
4.3 China Human Insulin Sales Volume and Market Share by Type (2013-2018)
4.4 China Human Insulin Sales Volume and Market Share by Application (2013-2018)
5 Europe Human Insulin (Volume, Value and Sales Price)
5.1 Europe Human Insulin Sales and Value (2013-2018)
5.1.1 Europe Human Insulin Sales and Growth Rate (2013-2018)
5.1.2 Europe Human Insulin Revenue and Growth Rate (2013-2018)
5.1.3 Europe Human Insulin Sales Price Trend (2013-2018)
5.2 Europe Human Insulin Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Human Insulin Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Human Insulin Sales Volume and Market Share by Application (2013-2018)
6 Japan Human Insulin (Volume, Value and Sales Price)
6.1 Japan Human Insulin Sales and Value (2013-2018)
6.1.1 Japan Human Insulin Sales and Growth Rate (2013-2018)
6.1.2 Japan Human Insulin Revenue and Growth Rate (2013-2018)
6.1.3 Japan Human Insulin Sales Price Trend (2013-2018)
6.2 Japan Human Insulin Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Human Insulin Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Human Insulin Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Human Insulin (Volume, Value and Sales Price)
7.1 Southeast Asia Human Insulin Sales and Value (2013-2018)
7.1.1 Southeast Asia Human Insulin Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Human Insulin Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Human Insulin Sales Price Trend (2013-2018)
7.2 Southeast Asia Human Insulin Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Human Insulin Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Human Insulin Sales Volume and Market Share by Application (2013-2018)
8 India Human Insulin (Volume, Value and Sales Price)
8.1 India Human Insulin Sales and Value (2013-2018)
8.1.1 India Human Insulin Sales and Growth Rate (2013-2018)
8.1.2 India Human Insulin Revenue and Growth Rate (2013-2018)
8.1.3 India Human Insulin Sales Price Trend (2013-2018)
8.2 India Human Insulin Sales Volume and Market Share by Players (2013-2018)
8.3 India Human Insulin Sales Volume and Market Share by Type (2013-2018)
8.4 India Human Insulin Sales Volume and Market Share by Application (2013-2018)
9 Global Human Insulin Players/Suppliers Profiles and Sales Data
9.1 Sanofi (France)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Human Insulin Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Sanofi (France) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly and Company (U.S.)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Human Insulin Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Biocon Ltd. (India)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Human Insulin Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Biocon Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Julphar (U.A.E.)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Human Insulin Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Julphar (U.A.E.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Ypsomed AG (Switzerland)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Human Insulin Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Ypsomed AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Becton
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Human Insulin Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Becton Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Dickinson and Company (U.S.)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Human Insulin Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Dickinson and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Wockhardt Ltd. (India)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Human Insulin Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Wockhardt Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 B. Braun Meselgen AG (Switzerland)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Human Insulin Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 B. Braun Meselgen AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Biodel Inc(U.S.)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Human Insulin Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Biodel Inc(U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
10 Human Insulin Maufacturing Cost Analysis
10.1 Human Insulin Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Human Insulin
10.3 Manufacturing Process Analysis of Human Insulin
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Human Insulin Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Human Insulin Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Human Insulin Market Forecast (2018-2025)
14.1 Global Human Insulin Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Human Insulin Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Human Insulin Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Human Insulin Price and Trend Forecast (2018-2025)
14.2 Global Human Insulin Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Human Insulin Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Human Insulin Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Human Insulin Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 China Human Insulin Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 Europe Human Insulin Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Human Insulin Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Human Insulin Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Human Insulin Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Human Insulin Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Human Insulin Sales Forecast by Type (2018-2025)
14.3.2 Global Human Insulin Revenue Forecast by Type (2018-2025)
14.3.3 Global Human Insulin Price Forecast by Type (2018-2025)
14.4 Global Human Insulin Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Human Insulin
Figure Global Human Insulin Sales Volume Comparison (Kg) by Type (2013-2025)
Figure Global Human Insulin Sales Volume Market Share by Type (Product Category) in 2017
Figure Short Acting Human Insulin Product Picture
Figure Intermediate Acting Human Insulin Product Picture
Figure Premixed Human Insulin Product Picture
Figure Global Human Insulin Sales Comparison (Kg) by Application (2013-2025)
Figure Global Sales Market Share of Human Insulin by Application in 2017
Figure Insulin Dependent Diabetes Mellitus Examples
Table Key Downstream Customer in Insulin Dependent Diabetes Mellitus
Figure Non-Insulin Dependent Diabetes Mellitus Examples
Table Key Downstream Customer in Non-Insulin Dependent Diabetes Mellitus
Figure Global Human Insulin Market Size (Million USD) by Regions (2013-2025)
Figure United States Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Human Insulin Sales Volume (Kg) and Growth Rate (2013-2025)
Figure Global Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Human Insulin Sales Volume (Kg) (2013-2018)
Table Global Human Insulin Sales (Kg) of Key Players/Suppliers (2013-2018)
Table Global Human Insulin Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Human Insulin Sales Share by Players/Suppliers
Figure 2017 Human Insulin Sales Share by Players/Suppliers
Figure Global Human Insulin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Human Insulin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Human Insulin Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Human Insulin Revenue Share by Players
Table 2017 Global Human Insulin Revenue Share by Players
Table Global Human Insulin Sales (Kg) and Market Share by Type (2013-2018)
Table Global Human Insulin Sales Share (Kg) by Type (2013-2018)
Figure Sales Market Share of Human Insulin by Type (2013-2018)
Figure Global Human Insulin Sales Growth Rate by Type (2013-2018)
Table Global Human Insulin Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Human Insulin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Insulin by Type (2013-2018)
Figure Global Human Insulin Revenue Growth Rate by Type (2013-2018)
Table Global Human Insulin Sales Volume (Kg) and Market Share by Region (2013-2018)
Table Global Human Insulin Sales Share by Region (2013-2018)
Figure Sales Market Share of Human Insulin by Region (2013-2018)
Figure Global Human Insulin Sales Growth Rate by Region in 2017
Table Global Human Insulin Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Human Insulin Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Human Insulin by Region (2013-2018)
Figure Global Human Insulin Revenue Growth Rate by Region in 2017
Table Global Human Insulin Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Human Insulin Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Human Insulin by Region (2013-2018)
Figure Global Human Insulin Revenue Market Share by Region in 2017
Table Global Human Insulin Sales Volume (Kg) and Market Share by Application (2013-2018)
Table Global Human Insulin Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Human Insulin by Application (2013-2018)
Figure Global Human Insulin Sales Market Share by Application (2013-2018)
Figure United States Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure United States Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Human Insulin Sales Price (USD/G) Trend (2013-2018)
Table United States Human Insulin Sales Volume (Kg) by Players (2013-2018)
Table United States Human Insulin Sales Volume Market Share by Players (2013-2018)
Figure United States Human Insulin Sales Volume Market Share by Players in 2017
Table United States Human Insulin Sales Volume (Kg) by Type (2013-2018)
Table United States Human Insulin Sales Volume Market Share by Type (2013-2018)
Figure United States Human Insulin Sales Volume Market Share by Type in 2017
Table United States Human Insulin Sales Volume (Kg) by Application (2013-2018)
Table United States Human Insulin Sales Volume Market Share by Application (2013-2018)
Figure United States Human Insulin Sales Volume Market Share by Application in 2017
Figure China Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure China Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Human Insulin Sales Price (USD/G) Trend (2013-2018)
Table China Human Insulin Sales Volume (Kg) by Players (2013-2018)
Table China Human Insulin Sales Volume Market Share by Players (2013-2018)
Figure China Human Insulin Sales Volume Market Share by Players in 2017
Table China Human Insulin Sales Volume (Kg) by Type (2013-2018)
Table China Human Insulin Sales Volume Market Share by Type (2013-2018)
Figure China Human Insulin Sales Volume Market Share by Type in 2017
Table China Human Insulin Sales Volume (Kg) by Application (2013-2018)
Table China Human Insulin Sales Volume Market Share by Application (2013-2018)
Figure China Human Insulin Sales Volume Market Share by Application in 2017
Figure Europe Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Europe Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Human Insulin Sales Price (USD/G) Trend (2013-2018)
Table Europe Human Insulin Sales Volume (Kg) by Players (2013-2018)
Table Europe Human Insulin Sales Volume Market Share by Players (2013-2018)
Figure Europe Human Insulin Sales Volume Market Share by Players in 2017
Table Europe Human Insulin Sales Volume (Kg) by Type (2013-2018)
Table Europe Human Insulin Sales Volume Market Share by Type (2013-2018)
Figure Europe Human Insulin Sales Volume Market Share by Type in 2017
Table Europe Human Insulin Sales Volume (Kg) by Application (2013-2018)
Table Europe Human Insulin Sales Volume Market Share by Application (2013-2018)
Figure Europe Human Insulin Sales Volume Market Share by Application in 2017
Figure Japan Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Japan Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Human Insulin Sales Price (USD/G) Trend (2013-2018)
Table Japan Human Insulin Sales Volume (Kg) by Players (2013-2018)
Table Japan Human Insulin Sales Volume Market Share by Players (2013-2018)
Figure Japan Human Insulin Sales Volume Market Share by Players in 2017
Table Japan Human Insulin Sales Volume (Kg) by Type (2013-2018)
Table Japan Human Insulin Sales Volume Market Share by Type (2013-2018)
Figure Japan Human Insulin Sales Volume Market Share by Type in 2017
Table Japan Human Insulin Sales Volume (Kg) by Application (2013-2018)
Table Japan Human Insulin Sales Volume Market Share by Application (2013-2018)
Figure Japan Human Insulin Sales Volume Market Share by Application in 2017
Figure Southeast Asia Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure Southeast Asia Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Human Insulin Sales Price (USD/G) Trend (2013-2018)
Table Southeast Asia Human Insulin Sales Volume (Kg) by Players (2013-2018)
Table Southeast Asia Human Insulin Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Human Insulin Sales Volume Market Share by Players in 2017
Table Southeast Asia Human Insulin Sales Volume (Kg) by Type (2013-2018)
Table Southeast Asia Human Insulin Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Human Insulin Sales Volume Market Share by Type in 2017
Table Southeast Asia Human Insulin Sales Volume (Kg) by Application (2013-2018)
Table Southeast Asia Human Insulin Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Human Insulin Sales Volume Market Share by Application in 2017
Figure India Human Insulin Sales (Kg) and Growth Rate (2013-2018)
Figure India Human Insulin Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Human Insulin Sales Price (USD/G) Trend (2013-2018)
Table India Human Insulin Sales Volume (Kg) by Players (2013-2018)
Table India Human Insulin Sales Volume Market Share by Players (2013-2018)
Figure India Human Insulin Sales Volume Market Share by Players in 2017
Table India Human Insulin Sales Volume (Kg) by Type (2013-2018)
Table India Human Insulin Sales Volume Market Share by Type (2013-2018)
Figure India Human Insulin Sales Volume Market Share by Type in 2017
Table India Human Insulin Sales Volume (Kg) by Application (2013-2018)
Table India Human Insulin Sales Volume Market Share by Application (2013-2018)
Figure India Human Insulin Sales Volume Market Share by Application in 2017
Table Sanofi (France) Basic Information List
Table Sanofi (France) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Sanofi (France) Human Insulin Sales Growth Rate (2013-2018)
Figure Sanofi (France) Human Insulin Sales Global Market Share (2013-2018)
Figure Sanofi (France) Human Insulin Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company (U.S.) Basic Information List
Table Eli Lilly and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales Global Market Share (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Revenue Global Market Share (2013-2018)
Table Biocon Ltd. (India) Basic Information List
Table Biocon Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Sales Growth Rate (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Sales Global Market Share (2013-2018
Figure Biocon Ltd. (India) Human Insulin Revenue Global Market Share (2013-2018)
Table Julphar (U.A.E.) Basic Information List
Table Julphar (U.A.E.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Sales Growth Rate (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Sales Global Market Share (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Revenue Global Market Share (2013-2018)
Table Ypsomed AG (Switzerland) Basic Information List
Table Ypsomed AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Sales Growth Rate (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Sales Global Market Share (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Revenue Global Market Share (2013-2018)
Table Becton Basic Information List
Table Becton Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Becton Human Insulin Sales Growth Rate (2013-2018)
Figure Becton Human Insulin Sales Global Market Share (2013-2018
Figure Becton Human Insulin Revenue Global Market Share (2013-2018)
Table Dickinson and Company (U.S.) Basic Information List
Table Dickinson and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Sales Growth Rate (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Sales Global Market Share (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Revenue Global Market Share (2013-2018)
Table Wockhardt Ltd. (India) Basic Information List
Table Wockhardt Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Sales Growth Rate (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Sales Global Market Share (2013-2018
Figure Wockhardt Ltd. (India) Human Insulin Revenue Global Market Share (2013-2018)
Table B. Braun Meselgen AG (Switzerland) Basic Information List
Table B. Braun Meselgen AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales Growth Rate (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales Global Market Share (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Revenue Global Market Share (2013-2018)
Table Biodel Inc(U.S.) Basic Information List
Table Biodel Inc(U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Sales Growth Rate (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Sales Global Market Share (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Insulin
Figure Manufacturing Process Analysis of Human Insulin
Figure Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Human Insulin Major Players in 2017
Table Major Buyers of Human Insulin
Table Distributors/Traders List
Figure Global Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure Global Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Human Insulin Price (USD/G) and Trend Forecast (2018-2025)
Table Global Human Insulin Sales Volume (Kg) Forecast by Regions (2018-2025)
Figure Global Human Insulin Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Human Insulin Sales Volume Market Share Forecast by Regions in 2025
Table Global Human Insulin Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Human Insulin Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Human Insulin Revenue Market Share Forecast by Regions in 2025
Figure United States Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure United States Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure China Human Insulin Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure Europe Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure Japan Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure India Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Human Insulin Sales (Kg) Forecast by Type (2018-2025)
Figure Global Human Insulin Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Human Insulin Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Human Insulin Revenue Market Share Forecast by Type (2018-2025)
Table Global Human Insulin Price (USD/G) Forecast by Type (2018-2025)
Table Global Human Insulin Sales (Kg) Forecast by Application (2018-2025)
Figure Global Human Insulin Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Insulin Glargine Market Research Report 2018
    Published: 19-Jun-2018        Price: US 2900 Onwards        Pages: 95
    This report studies the global Insulin Glargine market status and forecast, categorizes the global Insulin Glargine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with......
  • Global Insulin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. Scope of the Report: This rep......
  • Global Insulin API Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 12-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Insulin API Market 2018, Forecast to 2023
    Published: 12-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal i......
  • Global Liraglutide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jun-2018        Price: US 3480 Onwards        Pages: 137
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liraglutide Market 2018, Forecast to 2023
    Published: 11-Jun-2018        Price: US 4880 Onwards        Pages: 134
    Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition. ......
  • Global Diabetes Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Jun-2018        Price: US 3480 Onwards        Pages: 149
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Diabetes Drugs Market 2018, Forecast to 2023
    Published: 06-Jun-2018        Price: US 4880 Onwards        Pages: 148
    Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that's made by an organ called the pancreas. When the body doesn't make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems - including blindness, kidney damage, heart disease and stroke. That's why it's important to take medicine that helps l......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs